Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers

•Allogeneic stem cell transplantation is the only curative option for most T cell neoplasias relapsing after autologous stem cell transplantation, demonstrated by a 2-year overall survival and progression-free survival of 66% and 58%, respectively.•The performance status of preallogeneic stem cell t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation and cellular therapy 2021-06, Vol.27 (6), p.493.e1-493.e8
Hauptverfasser:	Novelli, Silvana, Bento, Leyre, Garcia, Irene, Prieto, Laura, López, Lucía, Gutierrez, Gonzalo, Hernani, Rafael, Pérez, Ariadna, Esquirol, Albert, Solano, Carlos, Bastos, Mariana, Dorado, Nieves, Rodríguez, Nancy, Rodríguez, Guillermo, Piñana, Jose L., Montoro, Juan, Herrera, Pilar, Luna, Alejandro, Parody, Rocío, Martín, Carmen, García, Estefanía, López, Oriana, Heras, Inmaculada, Zanabili, Joud, Moraleda, Jose M., Yañez, Lucrecia, Gutierrez, Antonio, Zudaire, Teresa, Córdoba, Raúl, Varela, Rosario, Ferra, Christelle, Martínez, Joaquin, Martínez, Carmen, Gonzalez-Barca, Eva, Martino, Rodrigo, Caballero, Dolores
Format:	Artikel
Sprache:	eng
Schlagworte:	Allogeneic stem cell transplantation Haploidentical T cell lymphoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!